Amylin Pharmaceuticals (AMLN)
Amylin Pharmaceuticals Cash and ST Investments: 315.30M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AMLN Cash and ST Investments Rankings
| Overall | 74th percentile | 1107 of 4365 |
| Sector | 83rd percentile | 81 of 504 in Healthcare |
| Industry | 88th percentile | 19 of 159 in Biotechnology |
AMLN Cash and ST Investments Range, Past 5 Years
| Minimum | 214.58M | Dec 2011 |
| Maximum | 1.141B | Jun 2007 |
| Average | 681.08M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these AMLN related companies
AMLN News
$AMLN low 30's easy on tues. Followed by buyout in mid to upper 30's
about 2 days ago by QR_Winner
about 2 days ago by QR_Winner
Sara Lee, Amylin Pharmaceuticals Included in Stocks Up on High Volume Friday
May 25, 4:34PM Fox Business
May 25, 4:34PM Fox Business
RT @markflowchatter Great alert by @TradeHawk on $AMLN as usual,recall that alot of the firms think a deal gets done at $30 - $37
about 2 days ago by epime7heus
about 2 days ago by epime7heus
RT @epime7heus everyone picking up some $AMLN in case of buyout just before or after holiday weekend <----- 3:30 pm yesterday
about 2 days ago by epime7heus
about 2 days ago by epime7heus
RT @tiernster $AMLN news says they received bids of at least $25? better b more then that - this is the 3rd time buyout talks increased pps
about 2 days ago by jackofalltrade
about 2 days ago by jackofalltrade
$AMLN news says they received bids of at least $25? better b more then that.
about 2 days ago by tiernster
about 2 days ago by tiernster
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
May 25, 2:01PM Street Insider
May 25, 2:01PM Street Insider
everyone picking up some $AMLN in case of buyout just before or after holiday weekend
about 3 days ago by epime7heus
about 3 days ago by epime7heus
RT @adamfeuerstein $AMLN Bydureon scripts flatfor the week although Victoza down 2.5% - scripts always seem to be highest first week of mth
about 6 days ago by jackofalltrade
about 6 days ago by jackofalltrade
$AMLN http://stks.co/3uVP Careful adding to the long. Divergence between MACD and Price action.
about 7 days ago by abdulalikon
about 7 days ago by abdulalikon
perfect time to sneak an $AMLN buyout in would be tomorrow before $FB opens at 11am
about 9 days ago by epime7heus
about 9 days ago by epime7heus
$AMLN http://stks.co/3qmJ could accelerate if it breaks out of rising wedge... http://stks.co/3qmK
about 11 days ago by TraderHR
about 11 days ago by TraderHR
Colgate-Palmolive, Amylin Pharmaceuticals, Other Stocks Hit 52-Week Highs Tuesday
May 15, 12:32PM Fox Business
May 15, 12:32PM Fox Business
Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference
Apr 30, 4:21PM Business Wire
Apr 30, 4:21PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AMLN | 27.96 | +2.16 | +8.37% | 4.496B |
| AMKR | 4.65 | +0.07 | +1.53% | 782.83M |
| AMJ | 37.36 | +0.23 | +0.62% | |
| AMIC | 4.35 | -0.34 | -7.25% | 35.97M |
| AMGN | 69.05 | -0.05 | -0.07% | 54.16B |
| AMG | 103.47 | -0.33 | -0.32% | 5.356B |
| AME | 49.22 | -0.44 | -0.89% | 7.911B |
| AMD | 6.22 | +0.20 | +3.32% | 4.350B |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AINV | 7.46 | -0.03 | -0.40% | 1.470B |
